ConductScience.org, home

Paper33859648

Roles of BTLA in Immunity and Immune Disorders.

Ning Z and 2 others. Front Immunol, 2021. Cited by 136 papers, by iCite.

Cite this record

ConductScience Library. Roles of BTLA in Immunity and Immune Disorders. Papers, record 33859648. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859648

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Roles of BTLA in Immunity and Immune Disorders.
PubMed
Journal
Front Immunol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
136
iCite
Relative citation ratio, by iCite
7.15
iCite
Revised in PubMed
2021-09-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ning ZZhaochen
2Liu KKeyan
3Xiong HHuabao

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immune System DiseasesMajor topic
ImmunityMajor topic
Lymphocyte ActivationMajor topic
Receptors, ImmunologicMajor topic
Animals
Autoimmunity
B-Lymphocytes
Dendritic Cells
Disease Susceptibility
Graft Rejection
Graft vs Host Disease
Humans
Organ Transplantation
T-Lymphocytes

Source PubMed

Download CSV of topics

References120

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117024343Association of a BTLA gene polymorphism with the risk of rheumatoid arthritis.J Biomed Sci2006https://conductscience.org/library/papers/17024343PubMed
231753019BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes.J Immunother Cancer2019https://conductscience.org/library/papers/31753019PubMed
330134817Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illness.Mol Med2018https://conductscience.org/library/papers/30134817PubMed
418193050CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.Nat Immunol2008https://conductscience.org/library/papers/18193050PubMed
529352109Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.Med Sci Monit2018https://conductscience.org/library/papers/29352109PubMed
627412504B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.Sci Rep2016https://conductscience.org/library/papers/27412504PubMed
724205056CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA.PLoS One2013https://conductscience.org/library/papers/24205056PubMed
819155498B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK.J Immunol2009https://conductscience.org/library/papers/19155498PubMed
924448587An agonistic anti-BTLA mAb (3C10) induced generation of IL-10-dependent regulatory CD4+ T cells and prolongation of murine cardiac allograft.Transplantation2014https://conductscience.org/library/papers/24448587PubMed
1027933341Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.Arch Immunol Ther Exp (Warsz)2016https://conductscience.org/library/papers/27933341PubMed
1127152329Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM.Sci Adv2016https://conductscience.org/library/papers/27152329PubMed
1221827810Dendritic cells expressing BTLA induces CD8+ T cell tolerance and attenuates the severity of diabetes.Vaccine2011https://conductscience.org/library/papers/21827810PubMed
1316725108Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA.Biochem Biophys Res Commun2006https://conductscience.org/library/papers/16725108PubMed
1430116751Distinct Changes of BTLA and HVEM Expressions in Circulating CD4+ and CD8+ T Cells in Hepatocellular Carcinoma Patients.J Immunol Res2018https://conductscience.org/library/papers/30116751PubMed
1519426226The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.Immunol Rev2009https://conductscience.org/library/papers/19426226PubMed
1625595777Cutting Edge: the BTLA-HVEM regulatory pathway interferes with protective immunity to intestinal Helminth infection.J Immunol2015https://conductscience.org/library/papers/25595777PubMed
1719567411Editorial: Therapeutic potential of targeting BTLA.J Leukoc Biol2009https://conductscience.org/library/papers/19567411PubMed
1826347741Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators.Front Immunol2015https://conductscience.org/library/papers/26347741PubMed
1932296431BTLA-Expressing Dendritic Cells in Patients With Tuberculosis Exhibit Reduced Production of IL-12/IFN-α and Increased Production of IL-4 and TGF-β, Favoring Th2 and Foxp3+ Treg Polarization.Front Immunol2020https://conductscience.org/library/papers/32296431PubMed
2031204070The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis.Immunity2019https://conductscience.org/library/papers/31204070PubMed

See all 120 referencesDownload CSV of references

Cited by105

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.

PMIDTitleJournalYearIn PapersSource
42973703Real-world clinical effectiveness and exploratory longitudinal immunological changes of Efgartigimod in myasthenia gravis: a retrospective study and a single-cell analysis in one patient.Front Neurol2026https://conductscience.org/library/papers/42973703PubMed
42929822Circulating Immune-Related Biomarkers in Egyptian Women with Early Breast Cancer: An Exploratory Case-Control Study Across IHC-Defined Clinicopathological Subgroups.Cells2026https://conductscience.org/library/papers/42929822PubMed
42816861Decoding the lncRNA landscape in bovine mastitis: insights into immune regulation and gene networks underlying host response.J Anim Sci Biotechnol2026https://conductscience.org/library/papers/42816861PubMed
42787587Harnessing tumor immune checkpoints for autoimmune disease therapeutics.Front Immunol2026https://conductscience.org/library/papers/42787587PubMed
42776797Molecular Architecture and Clinical Landscape of Immune Checkpoint Receptors and Ligands.Antibodies (Basel)2026https://conductscience.org/library/papers/42776797PubMed
42754905Role of BTLA in ovarian cancer and its clinical prognostic significance based on multi-omics analysis.J Ovarian Res2026https://conductscience.org/library/papers/42754905PubMed
42661746Monocyte-plasma cell communication characterizes treatment-associated peripheral immune remodeling in Guillain-Barré syndrome.Front Immunol2026https://conductscience.org/library/papers/42661746PubMed
42656703Single cell mapping of B and T cell dynamics in breast cancer lymph node metastasis.Front Bioinform2026https://conductscience.org/library/papers/42656703PubMed
42646567Elevated BTLA Expression Correlates with an Immunosuppressive Microenvironment and Defines Dysfunctional Circulating T Cells in Human Glioblastoma.Med Sci (Basel)2026https://conductscience.org/library/papers/42646567PubMed
42454039Lipidomics of HIV/HCV-related liver decompensation: association between plasma lipid depletion and immune dysregulation.Front Immunol2026https://conductscience.org/library/papers/42454039PubMed
42291367BTLA and PD-1 combined with radiotherapy for enhancing antitumor immune response in lung cancer via the regulation of memory B cells to promote T-cell infiltration.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42291367PubMed
42279386Advances in Immune Checkpoint Inhibitors for Cancer Treatment.Cancers (Basel)2026https://conductscience.org/library/papers/42279386PubMed
42182281Siglec-G on B cells restrains the germinal center response by controlling T cell help during positive selection.bioRxiv2026https://conductscience.org/library/papers/42182281PubMed
41826640Association between B and T lymphocyte attenuator/herpes virus entry mediator immunoregulatory axis and outcome prediction in a mixed critically ill population.Sci Rep2026https://conductscience.org/library/papers/41826640PubMed
41709280Immune regulation and cellular crosstalk drive non-fibrotic lung remodeling in pre-metamorphic frogs exposed to paraquat.BMC Biol2026https://conductscience.org/library/papers/41709280PubMed
41573577Transplanted gene-modified placental cells boost FVIII activity in pediatric sheep without eliciting immunity, toxicity, or adverse events.Front Immunol2025https://conductscience.org/library/papers/41573577PubMed
41530543A compendium of chromatin interaction maps in the Giant Panda genome.Commun Biol2026https://conductscience.org/library/papers/41530543PubMed
41486149Post-translational modifications of immune checkpoints: molecular mechanisms, tumor microenvironment remodeling, and therapeutic implications.J Biomed Sci2026https://conductscience.org/library/papers/41486149PubMed
41471273BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41471273PubMed
41440959The Search for Predictive Biomarkers in Response to Immune Checkpoint Inhibitors and Associated Adverse Events.J Pers Med2025https://conductscience.org/library/papers/41440959PubMed

See all 105 cited byDownload CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33859648

GET https://conductscience.org/api/papers/v1/33859648/references?page=2